Join to View Full Profile
1475 NW 12th AveMiami, FL 33136
Phone+1 305-243-1000
Fax+1 305-243-9927
Dr. Ardalan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of London Faculty of MedicineClass of 1970
Certifications & Licensure
CA State Medical License 1980 - Present
FL State Medical License 1991 - 2027
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Combination Chemotherapy as First-Line Therapy in Treating Patients With Stage IV Gastric Cancer That Cannot Be Removed By Surgery Start of enrollment: 2005 Jun 01
- Combination Chemotherapy in Treating Patients With Previously Untreated Stage II or Stage III Esophageal Cancer That Can Be Removed By Surgery Start of enrollment: 2004 Oct 01
- Arsenic Trioxide, Fluorouracil, and Leucovorin in Treating Patients With Stage IV Colorectal Cancer That Has Relapsed or Not Responded to Treatment Start of enrollment: 2005 Jun 01
- Join now to see all
Publications & Presentations
PubMed
- Distinct Molecular and Clinical Features of Specific Variants of KRAS Codon 12 in Pancreatic Adenocarcinoma.Bach Ardalan, Aaron Ciner, Yasmine Baca, Andrew Hinton, Sourat Darabi
Clinical Cancer Research. 2025-03-17 - Metastatic Pancreatic Adenocarcinoma Downstaged to T0N0 with Chemotherapy and Targeted Therapy, Confirmed by Surgical Pathology: A Case Report.Bach Ardalan, Alan Livingstone, Dido Franceschi, Danny Sleeman, Jose Azqueta
Case Reports in Oncology. 2024-07-29 - Case report: Diagnosis of NUT carcinoma of hepatic origin by next-generation sequencing.Bach Ardalan, Jose Azqueta, Jia Luo, Christopher French
Frontiers in Oncology. 2023-01-01
Grant Support
- Reversal Of 5-FU Resistance By Arsenic Trioxide In Colorectal CarcinomaNational Cancer Institute2007–2008
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
